JUNE 30, 2022 | 1-8PM ET
MassBio Hub | 700 Technology Square 5th floor
MPM Capital Sponsored Reception | Catalyst Restaurant
JUNE 30, 2022 | 1-8PM ET
MassBio Hub | 700 Technology Square 5th floor
MPM Capital Sponsored Reception | Catalyst Restaurant
For the 2022 theme we will discuss and debate the drivers of future breakthroughs in oncology across three major areas:
We've seen the emergence of new modalities for over a decade in an increasing number of therapeutic areas. These modalities, while still early, have progressed into the clinic mostly outside of oncology. The summit aims to facilitate a broad discussion on the future of in situ new modalities in oncology
Judy Lieberman
Endowed Chair, Cellular & Molecular Medicine, Boston Children’s
Professor of Pediatrics, Harvard Medical School
Uciane Scarlett
Principal, MPM Capital
Luke Timmerman
Founder & Editor, Timmerman Report
Dennis Chang
Managing Director, Clarion
Prashant Girinath
Partner, Greenberg Traurig
1:00 p.m. | Registration
1:30 p.m. | Welcome Remarks
1:40 p.m. | Research fire-side chat: State of the scientific landscape
2:20 p.m. | Innovation Bridge presentation: New Modalities at the Crossroads
2:50 p.m. | Innovation debate-style panel: Spectrum of new modalities
3:30 p.m. | People round table: Skills required to translate and implement
4:10 p.m. | Closing Remarks
4:30 – 8 p.m. | MPM hosted Reception
Summit: MassBio Hub | 700 Technology Square 5th floor, Cambridge, MA 02139
Reception: Catalyst Restaurant | 300 Technology Square, Cambridge, MA 02139
MassBioHub and Catalyst continue to stay up to date with the latest state and local COVID-19 guidelines and regulations.
Up to date guidance and requirements will be shared here closer to the date of the summit.
4th Annual Emerging Frontiers in Oncology
Copyright © 2021 Emerging Frontiers in Oncology - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.